نتایج جستجو برای: آنتی ژن cd133

تعداد نتایج: 32971  

ژورنال: :مجله طب پیشگیری طبری 0
بهنام هاشمی behnam hashemi graduate student of microbiology, faculty of medicine, mazandaran university of medical sciences, sari, iranدانشجوی کارشناسی ارشد میکروب شناسی، کمیته تحقیقات دانشجویی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران، ساری، ایران مریم عبداللهی maryam abdollahi graduate student of biostatistics, student research committee, faculty of medicine, mazandaran university of medical sciences, sari, iranدانشجوی کارشناسی ارشد آمار زیستی، کمیته تحقیقات دانشجویی، دانشکده بهداشت، دانشگاه علوم پزشکی مازندران، ساری، ایران عیسی نظر eisa nazar department of microbiology, cellular and molecular biology research center, faculty of medicine, mazandaran university of medical sciences, sari, iranگروه میکروب شناسی، مرکز تحقیقات بیولوژی سلولی و مولکولی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران، ساری، ایران محمد آهنجان mohammad ahanjan department of microbiology, cellular and molecular biology research center, faculty of medicine, mazandaran university of medical sciences, sari, iranگروه میکروب شناسی، مرکز تحقیقات بیولوژی سلولی و مولکولی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران، ساری، ایران

چکید ه مقدمه و هدف: هلیکوباکتر پیلوری یک باکتری گرم منفی، میکروآئروفیلیک و تاژک داری است که عامل بیماری های گوارشی مثل زخم معده و سرطان معده می باشد. هدف از این مطالعه، تشخیص عفونت هلیکوباکتر پیلوری با استفاده از آزمون آنتی ژن مدفوعی و سرولوژیک در شهر ساری می باشد. مواد و روش ها: در مطالعه حاضر، 120 بیمار مراجعه کننده به درمانگاه گوارش با علائم زخم معده و با متوسط سن  15تا 66 سال، انتخاب شدند. ...

2013
Yanhong Deng Manal M. Hassan Jianwen Mo Edward H. Lin

BACKGROUND CD133 is a marker that identifies/enriches cancer stem cell implicated in tumor initiation. We hypothesize that changes in the CD133 mRNA expression levels and vascular endothelial growth factor (VEGF) may correlate tumor response in GIST. METHODOLOGY/PRINCIPAL FINDINGS After informed consent, we obtained peripheral blood samples from 24 evaluable patients with gastrointestinal str...

Journal: :Cancer research 2007
Cosima V Pfenninger Teona Roschupkina Falk Hertwig Denise Kottwitz Elisabet Englund Johan Bengzon Sten Eirik Jacobsen Ulrike A Nuber

Human brain tumor stem cells have been enriched using antibodies against the surface protein CD133. An antibody recognizing CD133 also served to isolate normal neural stem cells from fetal human brain, suggesting a possible lineage relationship between normal neural and brain tumor stem cells. Whether CD133-positive brain tumor stem cells can be derived from CD133-positive neural stem or progen...

2017
Yeonhwa Song Jaewoo Jang Tae-Hoon Shin Sang Mun Bae Jin-sun Kim Kang Mo Kim Seung-Jae Myung Eun Kyung Choi Haeng Ran Seo

BACKGROUND CD133-positive cells in hepatocellular carcinoma (HCC) exhibit cancer stem cell (CSC)-like properties as well as resistance to chemotherapeutic agents and ionizing radiation; however, their function remains unknown. In this paper, we identified a hitherto unknown mechanism to overcome CD133-induced resistance to anticancer therapy. METHODS We applied an alternative approach to enri...

Journal: :The Journal of clinical investigation 2008
Mark A LaBarge Mina J Bissell

The concept of the so-called cancer stem cell (CSC) holds that only a minority of cells within a tumor have the ability to generate a new tumor. Over the last decade, a large body of literature has implicated the protein CD133 as a marker of organ-specific adult stem cells and in some cancers as a bona fide CSC marker. In this issue of the JCI, Shmelkov et al. challenge the view that CD133 is a...

Journal: :PLoS ONE 2008
Corinne E. Griguer Claudia R. Oliva Eric Gobin Pascale Marcorelles Dale J. Benos Jack R. Lancaster G. Yancey Gillespie

Mitochondria dysfunction and hypoxic microenvironment are hallmarks of cancer cell biology. Recently, many studies have focused on isolation of brain cancer stem cells using CD133 expression. In this study, we investigated whether CD133 expression is regulated by bioenergetic stresses affecting mitochondrial functions in human glioma cells. First, we determined that hypoxia induced a reversible...

Journal: :European review for medical and pharmacological sciences 2009
M A Puglisi A Sgambato N Saulnier F Rafanelli M Barba A Boninsegna A C Piscaglia C Lauritano M L Novi F Barbaro E Rinninella C Campanale F Giuliante G Nuzzo S Alfieri G B Doglietto A Cittadini A Gasbarrini

BACKGROUND "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsible for tumor initiation, maintenance and spreading. Although a universal marker for CSC has not yet been identified, CD133 has been proposed as the hallmark of CSC in colon cancer. The aim of our study was to assess the presence of a CD133+ cell fraction in samples of colon cancer and liver metastas...

Journal: :Cancer research 2011
Ines A Silva Shoumei Bai Karen McLean Kun Yang Kent Griffith Dafydd Thomas Christophe Ginestier Carolyn Johnston Angela Kueck R Kevin Reynolds Max S Wicha Ronald J Buckanovich

Markers that reliably identify cancer stem cells (CSC) in ovarian cancer could assist prognosis and improve strategies for therapy. CD133 is a reported marker of ovarian CSC. Aldehyde dehydrogenase (ALDH) activity is a reported CSC marker in several solid tumors, but it has not been studied in ovarian CSC. Here we report that dual positivity of CD133 and ALDH defines a compelling marker set in ...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012
Dylan Burger Alex Gutsol Anthony Carter David S Allan Rhian M Touyz Kevin D Burns

BACKGROUND Acute kidney injury (AKI) in humans has few therapeutic options. In experimental models, administration of progenitor cells facilitates recovery from AKI. Human umbilical cord-derived CD133(+) progenitor cells promote endothelial repair in ischemic limb, heart and brain tissue. METHODS We examined the effects of human CD133(+) progenitor cells in bilateral ischemia-reperfusion (I/R...

2016
Xiaofeng Wang Lu Chen Zhongdi Xiao Yali Wang Tiemei Liu Tianfu Zhang Yucheng Zhang

Cluster of differentiation (CD)133 is an important cell surface marker of glioma stem cells (GSCs). The transcription of the CD133 gene is controlled by five alternative promoters (P1, P2, P3, P4 and P5), which are expressed in a tissue-specific manner. In the present study, gene recombination technology was used to construct two types of gene expression vectors that contained the P1 promoter o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید